Mouse model of pulmonary disease after aerosol infection with mycobacterium xenopi

C. Andrejak, S. Tyagi, E. Nuermberger, J. Grosset (Baltimore, United States Of America)

Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Session: Clinical challenges in tuberculosis
Session type: Thematic Poster Session
Number: 2725
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Andrejak, S. Tyagi, E. Nuermberger, J. Grosset (Baltimore, United States Of America). Mouse model of pulmonary disease after aerosol infection with mycobacterium xenopi. Eur Respir J 2011; 38: Suppl. 55, 2725

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary and systemic inflammation in a domestic animal model of respiratory chlamydophila psittaci infection: Evaluation of dose-response relationships
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011

Tiotropium attenuates pulmonary inflammation in a novel mouse smoke RSV re-infection model
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014

Impact of pulmonary tuberculosis infection on chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Establishment of a murine asthma exacerbation model by combining OVA exposure with either RSV or influenza infection
Source: International Congress 2016 – Immune responses in the lung
Year: 2016

Impact of chronic bronchial infection on the lungs and beyond
Source: Eur Respir Monogr 2013; 60: 46-57
Year: 2013


Influenza infection affects the degree of fibrosis and apoptosis in the bleomycin mouse model
Source: Annual Congress 2013 –Interesting research questions
Year: 2013

The relationship between Mycobacterium avium complex infection and aspergillus lung disease in bronchiectasis
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010


Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease
Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017
Year: 2018



Pulmonary function after COVID-19 infection and the impact of disease severity.
Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Year: 2021



The burden of pulmonary hypertension
Source: Annual Congress 2006 - The burden of pulmonary hypertension
Year: 2006


Characterization of murine model of chronic M. abscessus respiratory infection.
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018

Impact of bacterial infections on airway diseases
Source: Eur Respir Rev 2005; 14: 62-68
Year: 2005



Risk of disease and latent infection among contacts of pulmonary and pleural tuberculosis in santarem (Portugal)
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009


Helicobacter pylori infection in COPD
Source: Annual Congress 2010 - Various aspects of respiratory epidemiology
Year: 2010

Plethysmography for the assessment of pneumococcal pneumonia and passive immunotherapy in a mouse model
Source: Eur Respir J 2001; 17: 94-99
Year: 2001



Chronic lung disease in CF mouse models, role of macrophages, treatment with azithromycin
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009

Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015

Impact of viruses on airway diseases
Source: Eur Respir Rev 2005; 14: 57-61
Year: 2005